Back
HUTCHMED (China) Vs. Takeda Pharmaceutical Industry Stock Comparison
Buy
70
HCM
HUTCHMED (China)
Last Price:
17.70
Seasonality Move:
3.48%
Sell
20
TAK
Takeda Pharmaceutical
Last Price:
13.33
Seasonality Move:
3.79%
Buy
70
HUTCHMED (China) (HCM)
is a Buy
Is HUTCHMED (China) a Buy, Sell or Hold?
- The current HUTCHMED (China) [HCM] share price is $17.68. The Score for HCM is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- HCM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Takeda Pharmaceutical (TAK)
is a Sell
Is Takeda Pharmaceutical a Buy, Sell or Hold?
- The current Takeda Pharmaceutical [TAK] share price is $13.33. The Score for TAK is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- TAK is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
HCM Stock Price Chart
What is HUTCHMED (China)'s stock price today?
-
The HUTCHMED (China) share price today is $17.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HCM is experiencing slight buying pressure.
TAK Stock Price Chart
What is Takeda Pharmaceutical's stock price today?
-
The Takeda Pharmaceutical share price today is $13.33
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TAK is experiencing buying pressure, which is a positive indicator for future bullish movement.
HCM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.57 | Sell |
| Relative Strength Index (14 RSI): | 45.05 | Sell |
| Chaikin Money Flow: | 4122 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.21 - 20.27) | Sell |
| Bollinger Bands (100): | (17.13 - 19.85) | Sell |
TAK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 34.17 | Sell |
| Chaikin Money Flow: | 2481819 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.52 - 14.04) | Sell |
| Bollinger Bands (100): | (13.54 - 14.68) | Sell |
HCM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.16 | Buy |
| 20-day SMA: | 18.18 | Sell |
| 50-day SMA: | 18.7 | Sell |
| 200-day SMA: | 17.94 | Sell |
| 8-day EMA: | 17.45 | Buy |
| 20-day EMA: | 18.01 | Sell |
| 50-day EMA: | 18.47 | Sell |
| 200-day EMA: | 17.98 | Sell |
TAK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.51 | Sell |
| 20-day SMA: | 13.71 | Sell |
| 50-day SMA: | 14.14 | Sell |
| 200-day SMA: | 13.89 | Sell |
| 8-day EMA: | 13.51 | Sell |
| 20-day EMA: | 13.7 | Sell |
| 50-day EMA: | 13.96 | Sell |
| 200-day EMA: | 14.07 | Sell |
HUTCHMED (China) Earnings Growth & HCM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.28 per share, and an increase next year of $0.42 per share.
Takeda Pharmaceutical Earnings Growth & TAK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
HUTCHMED (China) Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Takeda Pharmaceutical Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||